Strata Critical Medical, Inc. (SRTA) stock
SRTANasdaqTransportation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 17/3052% below fair value
$5.24−0.18 (-3.32%)
Close on Nov 17, 2026Market cap $463.57MP/E 10.3Yield –
Strata Critical Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Strata Critical Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$36.03M, down 2886.7% year over year. For fiscal 2025 it was -$48.91M. The highest annual figure on record is -$2.52M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$48.91M | – |
| FY2024 | Dec 31, 2024 | -$2.52M | – |
| FY2023 | Dec 31, 2023 | -$32.35M | – |
| FY2021 | Sep 30, 2021 | -$15.62M | – |
| FY2020 | Sep 30, 2020 | -$10.82M | – |
| FY2019 | Sep 30, 2019 | -$10.30M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | $5.69M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | $3.89M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$8.31M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$37.30M | -686.9% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$3.06M | -136.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$246.00K | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$1.75M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $6.36M | +214.1% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | $8.43M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$15.55M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$9.32M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | $2.02M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$8.20M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$16.86M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$5.79M | – |
See a number that looks wrong?